Eye Movement Parameters and Cognitive Functions in Older Adults
The Relationship Between Eye Movement Parameters and Cognitive Functions in Older Adults
1 other identifier
observational
210
1 country
1
Brief Summary
Dementia most commonly occurs in elderly individuals, but currently there is still a lack of objective measurement methods that can detect cognitive impairment in older adults at an early stage. Eye movement is considered a clinical indicator with potential for screening mild cognitive dysfunction, and eye movement signals can be extracted to objectively evaluate cognition. Eye tracking has been used mostly to evaluate patients with neurodegenerative diseases such as Parkinson's disease. However, less attention has been paid to the relationship between eye movement and cognitive function in elderly individuals, as well as the association between eye movement data and abnormal cognitive subdomains. This cross-sectional study will recruit 0204 elderly individuals over the age of 65, divided into three groups (healthy group/mild cognitive impairment group/dementia group) according to the purpose of this study. Participants who have not been diagnosed with neurological diseases (such as Parkinson's disease or stroke), or have mental illness or visual impairments will be excluded. This study hopes to provide empirical data on eye movement signals and cognitive function in healthy older individuals, as well as to serve as a preliminary study for future development of eye activity stimulation to improve cognitive function in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2026
CompletedStudy Start
First participant enrolled
January 17, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 23, 2026
January 1, 2026
12 months
January 5, 2026
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Eye-tracking measurement
Eye movement behavior will be assessed as an objective measure of cognitive control in older adults. Eye-tracking data will be collected using the J7EF Gaze Smart Glasses (Jorjin Technologies), a non-invasive wearable eye-tracking system with a sampling frequency of 30 Hz. Participants will perform standardized visual tasks while eye movement behavior is recorded. Outcome measures will include task-related eye movement patterns, such as gaze behavior and saccadic performance, which reflect attentional control and higher-order cognitive processing. Alterations in these eye movement parameters have been associated with cognitive impairment. Eye movement measures will be used to characterize differences in cognitive function across participant groups.
A single assessment is conducted at one study visit (cross-sectional design).
Secondary Outcomes (1)
Mini-Mental State Examination (MMSE)
A single assessment is conducted at one study visit (cross-sectional design).
Other Outcomes (6)
Eye-Tracking Task 1: Horizontal Fixation Task (HFT)
A single assessment is conducted at one study visit (cross-sectional design).
Eye-Tracking Task 2: Vertical Fixation Task (VFT)
A single assessment is conducted at one study visit (cross-sectional design).
Eye-tracking Task 3: Horizontal Pursuit Task (HPT)
A single assessment is conducted at one study visit (cross-sectional design).
- +3 more other outcomes
Study Arms (3)
Healthy group-patients with intact cognitive function
Mild cognitive impairment group-patients with mild cognitive impairment
Dementia group-patients with severe cognitive impairment
Eligibility Criteria
A total of 210 participants will be recruited, with an estimated 70 individuals in each cognitive group.
You may qualify if:
- \- Participants are aged 65 years or older and have completed a comprehensive geriatric assessment (CGA) in the outpatient clinic.
You may not qualify if:
- Participants are under 65 years of age or those who ar are unable to comply with study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Related Publications (1)
Pereira ML, Camargo Mv, Aprahamian I, Forlenza OV. Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease. Neuropsychiatr Dis Treat. 2014 Jul 9;10:1273-85. doi: 10.2147/NDT.S55371. eCollection 2014.
PMID: 25031536RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2026
First Posted
January 22, 2026
Study Start
January 17, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share